|
Jan 10
|
Gotham Slashes Grifols Short Position on Same Day as Selloff
|
|
Jan 10
|
Short Seller Attack Adds to Billionaire Grifols Dynasty Pain
|
|
Jan 10
|
Spain's Grifols to sue short-seller over critical report, shares jump
|
|
Jan 9
|
Factbox-What does the Gotham City report say about Grifols?
|
|
Jan 9
|
Grifols Denies Gotham Claims as Short Seller Triggers 26% Rout
|
|
Jan 9
|
Factbox-What is Grifols and why have its shares slumped?
|
|
Jan 9
|
Grifols Stock Tanks, Short Seller Alleges Profit Manipulation, Concerning Financial Health
|
|
Jan 9
|
Grifols Sinks as Short Seller Gotham Criticizes Accounting
|
|
Jan 9
|
Spain's Grifols slumps after short-seller accuses healthcare group of fraud
|
|
Jan 9
|
Gotham City accounting queries wipe $3 billion off Grifols value
|
|
Dec 7
|
GRFS vs. ZTS: Which Stock Is the Better Value Option?
|
|
Jul 18
|
Grifols Completes Enrollment in Phase 3 Study of Long-term Albutein® (albumin-human injection) Therapy for Patients with Decompensated Cirrhosis
|
|
Jul 13
|
Grifols Meets Enrollment Target in Phase 3 Study of Two Dose Regimens of Prolastin®-C in Patients with Emphysema Due to Alpha-1-Antitrypsin Deficiency
|